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Abstract
Cytomegaloviruses (CMVs) are master manipulators of the host
immune response. Here, we reveal that the murine CMV (MCMV)
protein m152 specifically targets the type I interferon (IFN) response
by binding to stimulator of interferon genes (STING), thereby delay-
ing its trafficking to the Golgi compartment from where STING initi-
ates type I IFN signaling. Infection with an MCMV lacking m152
induced elevated type I IFN responses and this leads to reduced viral
transcript levels both in vitro and in vivo. This effect is ameliorated
in the absence of STING. Interestingly, while m152 inhibits STING-
mediated IRF signaling, it did not affect STING-mediated NF-jB
signaling. Analysis of how m152 targets STING translocation reveals
that STING activates NF-jB signaling already from the ER prior to its
trafficking to the Golgi. Strikingly, this response is important to
promote early MCMV replication. Our results show that MCMV has
evolved a mechanism to specifically antagonize the STING-mediated
antiviral IFN response, while preserving its pro-viral NF-jB response,
providing an advantage in the establishment of an infection.
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Introduction
Host defense against infection requires the early recognition of invad-
ing pathogens by pattern recognition receptors (PRR). DNA derived
from pathogens, such as DNA viruses, is a potent pathogen-associated
molecular pattern (PAMP), which can be detected by DNA sensors
and thereby trigger the production of type I interferons (IFN) and
proinflammatory cytokines. Although several DNA sensors have
been described, the cyclic guanosine monophosphate-adenosine
monophosphate (cGAMP) synthase (cGAS) is considered the major
sensor of cytosolic DNA (Sun et al, 2013). DNA binding to cGAS
leads to the production of the second messenger 2030-cGAMP,
which then directly binds to the endoplasmic reticulum (ER)-resi-
dent protein stimulator of interferon genes (STING) (Ishikawa &
Barber, 2008). STING is composed of four transmembrane domains
and a long cytoplasmic C terminus (Ouyang et al, 2012). Upon acti-
vation, STING undergoes dimerization via its C-terminal domain
and then translocates from the ER to the Golgi compartment, where
it binds to and is phosphorylated by the TANK-binding kinase 1
(TBK1) leading to phosphorylation and activation of the transcrip-
tion factor interferon regulatory factor 3 (IRF3) and type I IFN tran-
scription (Liu et al, 2015). Moreover, STING can also activate
nuclear factor kappa-light-chain-enhancer of activated B cell (NF-
jB)-dependent signaling; however, the exact mechanism and
subcellular compartment from where this signaling pathway is acti-
vated remains poorly understood. Previous findings suggest that
STING activates canonical and non-canonical NF-jB activation via
the TNF receptor associated factor 6 (TRAF6)-TBK1 axis and TRAF3,
respectively (Abe & Barber, 2014).
STING is essential for the innate immune response to a variety of
viral pathogens. Herpes simplex virus type 1 (HSV-1) was the first
DNA virus reported to induce the cGAS-STING pathway (Li et al,
2013). Mice lacking cGAS or STING were shown to be susceptible to
HSV-1 infection (Reinert et al, 2016). Similar observations were
made for several other herpesviruses such as Kaposi’s sarcoma-
associated herpesvirus (KSHV) (Ma et al, 2015), human cytomega-
lovirus (HCMV) (Paijo et al, 2016), and murine cytomegalovirus
(MCMV) (Lio et al, 2016; Chan et al, 2017). The initial burst of type
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I IFN production upon MCMV infection was shown to be dependent
on STING (Lio et al, 2016). It follows then that herpesviruses
would have evolved discreet mechanisms to overcome this path-
way, which is an important source of the potent antiviral type I
IFN response.
Through millions of years of co-evolution, herpesviruses have
developed effective strategies to moderate immune control for secur-
ing lifelong persistence in their respective hosts. In the case of CMV,
viral immune evasion of natural killer (NK) cell- and T cell-mediated
responses has been identified and well characterized (Lemmermann
et al, 2012; Lisnic et al, 2015). However, the mechanism by which
CMV evades innate immune control following PRR signaling
remains poorly understood. MCMV is a well-established model to
study the delicate balance between CMV and its host. So far, no
MCMV protein has been identified to specifically target the cGAS-
STING pathway, and no study has described the in vivo influence of
a beta-herpesviral cGAS-STING modulator.
Here, we describe m152 as the first MCMV protein to specifically
engage the adaptor protein STING within the first few hours of
infection. m152, which is an ER-resident type I transmembrane
protein, has been previously reported to efficiently thwart both NK-
and T cell-dependent immune responses by preventing cell surface
expression of the NKG2D ligand retinoic acid early inducible gene-1
(RAE-1) and major histocompatibility complex class I molecules
(MHC class I), respectively (Ziegler et al, 1997; Krmpotic et al,
1999; Lodoen et al, 2003; Fink et al, 2013). We now show that
m152 additionally modulates the cGAS-STING pathway, indepen-
dently of its effect on NK- and T cell-mediated responses. At a very
early time point after MCMV infection, m152 perturbs the translo-
cation of activated STING from the ER to the Golgi compartment
and thereby inhibits the type I IFN response to MCMV infection.
Interestingly, m152 has no effect on STING-mediated NF-jB activa-
tion, which suggests that STING may activate NF-jB signaling
prior to trafficking. We observed both in vitro and in vivo that the
inhibitory effect of m152 generates a permissive environment result-
ing in enhanced viral transcription. However, the absence of STING
does not create an advantage for MCMV replication in the first hours
of infection, which suggests that STING may have a pro-viral role.
We made use of the ability of m152 to selectively delay STING
translocation from the ER to the Golgi to show that STING activates
NF-jB signaling already from the ER and that this response is indeed
beneficial for early MCMV transcription. This study highlights a dual
role for STING in the context of MCMV infection, as well as the
resourcefulness of MCMV in encoding a single viral protein targeting
three major immune responses to foster an optimal environment for
establishing a successful infection in the host.
Results
The MCMV m152 protein specifically downmodulates STING-
dependent type I IFN induction
Recently, it was shown that the initial type I IFN response upon
MCMV infection depends on the key adaptor protein STING (Lio
et al, 2016), which mediates signaling downstream of cytosolic
DNA sensing. Since MCMV has evolved a plethora of evasion strate-
gies to modulate innate and adaptive immune responses, we
hypothesized that MCMV would have evolved a mechanism to
counteract the STING-mediated innate immune response. To
address this, we developed an unbiased luciferase-based reporter
assay in 293T cells to screen for modulators of IFNb transcription
encoded by MCMV. As 293T cells do not express endogenous cGAS
or STING, we reconstituted the pathway by transiently expressing a
murine Cherry-STING fusion protein and induced signaling by co-
expression of cGAS-GFP. To monitor IFNb induction, a reporter
plasmid composed of the murine IFNb promoter upstream of the
firefly luciferase gene (IFNb-Luc) was co-transfected. In total, 173
MCMV open reading frames (ORFs) (Munks et al, 2006) were tested
for their ability to inhibit the cGAS-STING pathway (Appendix Fig
S1). Among the MCMV proteins tested, the MCMV type I transmem-
brane protein m152 significantly inhibited IFNb promoter activity
downstream of cGAS-STING signaling to a similar extent as the
known IRF3 antagonist KSHV ORF36 (Hwang et al, 2009) compared
to either empty vector (ev) or the cellular type I transmembrane
protein CD4 (Fig 1A). To investigate whether m152 targets multiple
PRR-mediated signaling pathways, we co-expressed RIG-I N, a
constitutively active form of the cytosolic RNA sensor RIG-I. As
expected, influenza NS1, an antagonist of RIG-I signaling, markedly
inhibited IFNb promoter induction, whereas m152, as for the control
CD4, had no effect on RIG-I signaling (Fig 1B). Upon overexpression
of TBK1 or expression of a constitutively active form of IRF3 (IRF3-
5D) (Lin et al, 1998), m152 expression had no effect on type I IFN
induction (Fig 1C and D). Additionally, to exclude an effect of m152
on interferon-a/b receptor (IFNAR) signaling, 293T cells were
co-transfected with an ISG56 promoter firefly luciferase reporter
construct and IFNAR signaling was activated by the addition of
recombinant IFNb. MCMV M27, a known modulator downstream of
IFNAR-dependent signaling (Zimmermann et al, 2005), inhibited
ISG56 promoter induction, whereas m152 did not have an effect
(Fig 1E). Thus far, these results suggest that the MCMV m152
protein specifically targets STING-dependent signaling prior to the
activation of the kinase TBK1 and the transcription factor IRF3.
To validate our results in a more physiological setting, we
examined the effect of m152 on IFNb transcription in murine
embryonic fibroblasts (MEF). For this, we utilized immortalized
goldenticket MEF (iMEFgt/gt), which do not express endogenous
STING due to an I199N missense mutation in STING (Sauer et al,
2011; Appendix Fig S2A). We reconstituted STING expression in
these cells by transducing them with a murine Cherry-STING
fusion construct resulting in iMEFgt/gt Cherry-STING. These cells
were additionally transduced to stably express V5-tagged m152,
and the expression was verified by immunoblotting (Appendix Fig
S2A). Upon stimulation with interferon-stimulatory DNA (ISD),
we observed an inhibition of IFNb transcription in m152 express-
ing cells (Fig 1F). In contrast, upon stimulation with the RLR
ligand poly(I:C), the presence of m152 did not affect IFNb tran-
scription (Fig 1G).
Since the cGAS-STING signaling pathway is crucial to mount a
potent type I IFN response upon MCMV infection in macrophages
(Chan et al, 2017), we addressed whether m152 expression reduces
IFNb secretion in this cell type. We generated immortalized bone
marrow-derived macrophages (iBMDM) stably expressing V5-tagged
m152 (Appendix Fig S2B). As expected, upon stimulation with 2030-
cGAMP or ISD, lower levels of secreted IFNb were detected in the
presence of m152 (Fig 1H and I). In contrast, m152 had no effect
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on Newcastle disease virus (NDV)-induced RIG-I signaling
(Yoneyama et al, 2004) (Fig 1J), nor did it affect CpG-induced TLR9
signaling (Fig 1K). Collectively, these data show that m152
selectively targets cGAS-STING signaling upstream of the TBK1-
IRF3 axis, but does not affect RIG-I-, TLR9-, or IFNAR-mediated
signaling.
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Figure 1. The MCMV m152 protein specifically targets STING-dependent signaling.
A 293T cells were co-transfected with expression plasmids for Cherry-STING, the murine IFNb-luciferase reporter (IFNb-Luc), a Renilla luciferase normalization
control (pRL-TK), and the indicated expression plasmids or empty vector (ev). Cells were additionally co-transfected with expression plasmids for cGAS-GFP
(stimulated) or IRES-GFP (unstimulated). 20 hours post-transfection, cells were lysed and a dual-luciferase assay was performed.
B An expression plasmid for RIG-I N (stimulated) or ev (unstimulated) was co-transfected with IFNb-Luc, pRL-TK and the indicated expression plasmids in 293T cells
and analyzed as in (A).
C An expression plasmid for TBK1 (stimulated) or ev (unstimulated) was co-transfected together with IFNb-Luc, pRL-TK and the indicated expression plasmids and
analyzed as in (A).
D 293T cells were co-transfected with a plasmid expressing constitutively active IRF3 (IRF3-5D; stimulated) or IRES-GFP (unstimulated) together with IFNb-Luc, pRL-
TK and the indicated expression plasmids and analyzed as in (A).
E The ISG56-luciferase reporter, pRL-TK, and the indicated expression plasmids were co-transfected in 293T cells. 24 hours post-transfection, cells were stimulated
with 0.1 ng/ll human IFNb or mock stimulated and analyzed 16 h later as described in (A).
F, G iMEFgt/gt stably expressing Cherry-STING and either ev or V5-tagged m152 were stimulated with 5 lg/ml ISD (F), 10 lg/ml poly(I:C) (G), or mock stimulated with
Lipofectamine. 4 hours post-stimulation, RNA was extracted to determine IFNb mRNA transcripts by qRT–PCR.
H–K iBMDM stably expressing ev or m152-V5 were stimulated in duplicates with 10 lg/ml cGAMP (H), 5 lg/ml ISD (I), Newcastle disease virus (NDV) infection (J), or
1 lM CpG DNA (K). 6 (H) or 16 (I-K) hours later, secreted IFNb (H-J) or TNFa (K) levels were determined by ELISA.
Data information: (A-G) Data are combined from three independent experiments. (H-K) Experiments were performed three (H, I, K) or two (J) times independently and
one representative experiment is shown. Student’s t-test (unpaired, two-tailed), n.s. not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data are shown
as mean  SD.
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m152 co-localizes and interacts with STING in resting and
stimulated cells
In unstimulated cells, STING is localized in the ER (Ouyang et al,
2012). Upon activation, STING translocates from the ER to the
Golgi compartment, which is a crucial prerequisite for downstream
signaling leading to the induction of the type I IFN response
mediated by TBK1 and IRF3 (Liu et al, 2015).
MCMV m152 is likewise described as an ER-resident protein (Ziegler
et al, 1997) and as we have observed that m152 targets STING-
mediated signaling, we sought to examine whether m152 translocates
together with STING. For this, we first transfected HeLa cells with
expression constructs for murine Cherry-STING and V5-tagged m152.
As expected, STING and m152 co-localized in the ER in unstimulated
cells (Fig 2A, upper panel). Upon overexpression of cGAS-GFP to acti-
vate STING-dependent signaling, we observed that STING translocated
to the perinuclear region as described previously (Ishikawa et al, 2009)
(Fig 2A, lower panel). Notably, m152 co-localized with STING in the
perinuclear region. This shows that, like STING, m152 translocates
upon stimulation of the cGAS-STING pathway.
Subsequently, we wanted to address whether the translocation of
m152 upon cGAS activation is STING-dependent. When transfecting
iMEFgt/gt with an expression plasmid for V5-tagged m152 alone,
m152 was detected in the ER (Fig 2B, first panel). When we recon-
stituted STING expression, m152 and STING co-localized in the ER
and upon overexpression of cGAS, both proteins translocated to the
A
B
C
D
Figure 2. STING and the MCMV m152 protein co-localize and interact under unstimulated and stimulated conditions.
A, B (A) HeLa cells were co-transfected with expression plasmids for Cherry-STING, V5-tagged m152, and either ev (unstimulated) or cGAS-GFP (stimulated). (B) iMEFgt/gt
were co-transfected with expression plasmids for V5-tagged m152 together with either Cherry-STING or ev in combination with cGAS-GFP (stimulated) or ev
(unstimulated). Twenty-four hours post-transfection, cells were fixed for immunolabeling with an anti-V5 antibody. White boxes indicate the region shown at a
higher magnification. Scale bar represents 10 lm.
C Lysates of Cherry-STING and either CD4-V5 or m152-V5 expressing 293T cells were subjected to immunoprecipitation (IP) with an anti-V5 antibody. Input and IP
samples were analyzed by IB with the indicated antibodies.
D iMEF stably expressing ev or m152-V5 were left unstimulated or stimulated with 10 lg/ml ISD and lysed 90 min later. m152 was immunoprecipitated with an anti-
V5 antibody, and samples were analyzed by IB with V5, STING, and phospho-TBK1 (pTBK1)-specific antibodies.
Data information: IB shown are representative of three (C) or two (D) independent experiments.
Source data are available online for this figure.
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perinuclear region (Fig 2B, second and third panel), consistent with
our results in HeLa cells. Notably, upon co-transfection with cGAS
and in the absence of STING, m152 remained in the ER and did not
translocate to the perinuclear region (Fig 2B, last panel), suggesting
that the translocation of m152 is dependent on STING. Since m152
and STING translocate simultaneously upon stimulation, we sought
to examine whether these proteins interact with each other. Upon
overexpression in 293T cells, STING co-immunoprecipitated with
m152, but not with the control protein CD4 (Fig 2C). To show that
m152 interacts with endogenous STING, we generated iMEF stably
expressing V5-tagged m152 (Appendix Fig S2C) and either left them
unstimulated or stimulated with ISD. Endogenous STING co-immu-
noprecipitated with m152 in unstimulated as well as stimulated cells
(Fig 2D), correlating with our observation that m152 and STING
co-localize regardless of stimulation status.
The luminal N-terminal domain of m152 directs its interaction
with STING
Next, we aimed to identify the domain of m152 which is essential for
its interaction with STING and its effect on STING-mediated signaling.
We constructed a series of chimeric m152 proteins by exchanging
target domains singly or in combination with the corresponding region
in CD4 (Fig 3A, (1)-(6)), a well-characterized cellular type I transmem-
brane protein which was previously used for the generation of
chimeric proteins (Ziegler et al, 2000; Barton et al, 2006). All gener-
ated m152 mutants were expressed in 293T cells, and their localization
was determined in unstimulated and stimulated conditions. Excepting
the CD4-m152SPCTD (5) mutant, which only partially localizes with
STING, wild-type m152 and all m152 mutants (1–4 and 6) co-localize
with STING in unstimulated and stimulated cells (Fig EV1A). Next, we
analyzed the m152-CD4 chimeric proteins in the established IFNb luci-
ferase reporter assay described previously. We observed that all m152
chimeras that still contained the luminal domain of m152 (1–4)
retained the ability to inhibit signaling downstream of cGAS-STING
(Fig 3B). Both m152-CD4 chimeric proteins where the N-terminal
domain of m152 was replaced with that of CD4, namely CD4-
m152SPCTD (5) and CD4-m152SPTMCTD (6), lost the ability to inhibit
STING-mediated signaling (Fig 3B), showing that the N-terminal
domain of m152 is responsible for its effect on STING signaling. Co-IP
experiments in 293T cells confirmed that the N-terminal domain of
m152 mediates its interaction with STING, whereas the transmem-
brane and C-terminal domain of m152 are inconsequential (Fig 3C).
We also constructed an m152 mutant lacking N-linked glycosylation
(Fink et al, 2013) (Fig 3A, (7)) and observed that post-translational N-
linked glycosylation of m152 does not contribute to the impeding effect
of m152 on STING-dependent signaling (Fig EV1B). In addition, we
mutated the stalk region of m152, which is required for its binding to
and effect on MHC class I (Janssen et al, 2016) (Fig 3A, (8)+(9)), and
can show that this region is dispensable for its effect on STING signal-
ing and interaction with STING (Fig 3D and E). These m152 mutants
(7–9) also still co-localized with STING (Fig EV1A).
The luminal loop regions of STING are the sites of interaction
with m152
CMV and their respective hosts share a dynamic co-evolution span-
ning millions of years. While the m152 protein is highly conserved
among various MCMV strains, there is no known homologue in
HCMV. Interestingly, we observed that m152 selectively inhibited
IFNb promoter activity downstream of murine STING (mSTING),
but not human STING (hSTING) (Fig 4A).
To better understand why the effect of m152 is restricted to
murine STING, we compared the protein sequences of murine and
human STING and noted that, while the C-terminal domain of
STING is conserved between both species, the predicted ER-luminal
loop regions of STING are variable (Fig 4B). Since we have
observed that the N-terminal domain of m152, which is localized in
the ER lumen, is crucial for its interaction with STING, it raised the
possibility that the loop regions of STING, which are likewise lumi-
nal, may be the reciprocal interaction site (Fig 4B).
To address this, we expressed various murine or human STING
chimeras in the IFNb luciferase assay to see which mutants would
remain targets of m152. First, we introduced an N41E mutation into
the first luminal loop region or replaced the second luminal loop region
in murine STING with the respective sequences in human STING singly
or in combination. Vice versa mutations were introduced in human
STING (Fig 4B). The functionality of these STING mutants compared
to WT murine or human STING was verified (Appendix Fig S3A).
Upon induction of the IFNb promoter following overexpression of
murine STING in which either the N41E mutation was introduced
(mSTING-N41E) or the second loop region was exchanged (mSTING-
hL2), m152 partially lost the ability to inhibit IFNb promoter activity
(Fig 4C). However, when both loops of murine STING were mutated
(mSTING-N41E-hL2), m152 could no longer downmodulate signal-
ing, just as m152 did not inhibit signaling downstream of human
STING (Fig 4C). Co-immunoprecipitation experiments in 293T cells
confirmed that these sites in STING also mediate its interaction with
m152 (Fig 4D, lane 4; Appendix Fig S3B).
Similarly, signaling of human STING with introduced murine
STING loop regions, namely hSTING-E41N and hSTING-mL2, was
partially inhibited by m152, and hSTING-E41N-mL2 was inhibited
by m152 similar to murine STING (Fig 4E). Likewise, while m152
interacted with hSTING only weakly (Fig 4F, lane 1), it co-precipi-
tated with the human STING chimeras with murine STING loop
regions (Fig 4F, lane 2–4; Appendix Fig S3B).
Altogether, these data reveal that m152 binds to both luminal
loop regions of murine STING to exert its antagonistic effect on the
STING-mediated type I IFN response.
m152 antagonizes STING translocation, but not its activation
or dimerization
Upon stimulation, STING follows a series of distinct steps prior to the
activation of TBK1 and IRF3 and subsequent type I IFN transcription.
Sequentially, these include the activation by 2030-cGAMP (i) and
dimerization of STING (ii), its ER exit (iii), and translocation to the
Golgi compartment (iv), where it activates downstream signaling via
TBK1 and IRF3 (Fig 5A). We therefore sought to pinpoint which step
m152 may target to inhibit STING-dependent signaling.
To assess whether m152 targets STING activation by cGAMP, we
generated a ligand-independent, constitutively active mutant of
STING by introducing a single aa substitution (V154M) (Jeremiah
et al, 2014). As expected, expression of STING WT in the absence of
cGAS did not lead to activation of the IFNb promoter (Fig 5B). In
comparison, expression of STING V154M induced activation of the
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IFNb promoter, confirming that this STING mutant can trigger
downstream signaling independent of an activation step via cGAS.
Nonetheless, in the presence of m152, signaling of STING V154M
was still inhibited (Fig 5B), suggesting that m152 does not target
STING activation by cGAMP, as observed before (Fig 1H).
To investigate whether m152 inhibits STING dimerization, we
stimulated iMEF stably expressing m152 or corresponding control
cells with ISD and assessed for the presence of STING dimers after
stimulation (Fig 5C). We did not observe an effect in the kinetics
of STING dimer formation when m152 was present (Fig 5C),
A B
C D E
Figure 3. The N-terminal domain of m152 directs the interaction with STING.
A Schematic representation of wild-type m152, wild-type CD4, CD4-m152 chimeric constructs, m152 glycosylation mutants, and m152 stalk mutants used in this study.
CD4-m152 chimeras (1–6): The relevant domain of m152 was replaced singly or in combination with the respective domain of murine CD4. m152 glycosylation
mutant (7): asparagine (N) at position 83, 230, and 263 was mutated to glutamine (Q). m152 stalk mutants (8-9): m152-Dstalk has a deletion of amino acids 300-326
(8), and for m152-GSstalk, a glycine-serine linker ((G4S)5) was inserted to replace the stalk region (9). SP = signal peptide, NTD = N-terminal domain,
TM = transmembrane domain, CTD = C-terminal domain. Branched symbols represent the three glycosylation sites of m152.
B Cherry-STING, IFNb-Luc, pRL-TK, cGAS-GFP (stimulated), or IRES-GFP (unstimulated) and indicated expression plasmids as shown in (A) were transiently expressed in
293T cells and a dual-luciferase assay was performed. Data are combined from two out of three independent experiments and shown as mean  SD.
C 293T cells were co-transfected with expression plasmids for Cherry-STING and indicated chimeras as shown in (A). An anti-V5 IP was performed, and samples were
analyzed by IB with indicated antibodies. IB shown is representative of three independent experiments.
D Cherry-STING, IFNb-Luc, pRL-TK, and either CD4, m152, m152-Dstalk, or m152-GSstalk were transiently expressed in 293T cells. For stimulation, samples were co-
transfected with cGAS-GFP, and unstimulated samples with IRES-GFP. Lysates were analyzed as described in (B). Data are combined from two out of three
independent experiments and shown as mean  SD.
E 293T cells were co-transfected with expression plasmids for Cherry-STING and either CD4, m152, m152-Dstalk, or m152-GSstalk. An anti-V5 IP was performed, and
samples were analyzed by IB with indicated antibodies. Immunoblot shown is representative of three independent experiments.
Data information: Student’s t-test (unpaired, two-tailed), n.s. not significant, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Source data are available online for this figure.
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which shows that m152 also does not affect the dimerization of
STING.
Consistent with previous reports, we have observed that the ER-
resident STING protein translocates to the perinuclear region following
activation (Fig 2A). To determine whether m152 affects the transloca-
tion kinetics of STING, we stimulated iMEFgt/gt Cherry-STING with
ISD and monitored the translocation of STING by live cell imaging. As
shown in Fig 5D, STING localizes in the ER in unstimulated cells and
A B
C D
E F
Figure 4.
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upon stimulation, STING was present in clearly distinguishable perin-
uclear structures, which were used as a marker to quantify STING
translocation. When we introduced m152 into these cells, we
observed that the percentage of cells exhibiting translocated STING
was markedly reduced compared to control cells (Fig 5E, representa-
tive images are shown in Fig EV2A). These data suggest that m152
delays the translocation of STING following its activation.
Upon stimulation of iMEF stably expressing m152 with ISD in the
presence of Brefeldin A, which inhibits protein transport from the ER
to the Golgi compartment, STING dimers were detected; however,
phosphorylation of TBK1 did not occur (Fig EV2B). As already
observed by others (Mukai et al, 2016), this suggests that STING
dimerizes at the ER, whereas its translocation to the Golgi is a prereq-
uisite for the activation of TBK1. Since STING translocation is impor-
tant for the activation of TBK1 and therefore for the downstream
activation of IRF3, we hypothesized that the hindrance of STING
translocation by m152 would affect the phosphorylation of TBK1,
IRF3, and STING itself. To test this hypothesis, we stimulated iMEFgt/gt
stably expressing Cherry-STING and either m152 or the corresponding
control cells with ISD and assayed for the phosphorylation of TBK1,
IRF3, and STING in a time course (Fig 5F). In control cells, phosphory-
lation of TBK1 was already detected 30 min post-stimulation, while at
the same time point in the presence of m152, TBK1 remained unmodi-
fied. Likewise, 90 min post-stimulation, phosphorylated IRF3 could be
detected in control, but not in m152 expressing cells (Fig 5F).
However, by 180 min post-ISD stimulation, phosphorylated TBK1
levels were comparable, regardless of the presence or absence of
m152, while levels of phosphorylated IRF3 were still affected by the
presence of m152, matching our observations from the live cell imag-
ing experiments. Comparable results were also observed with endoge-
nous STING in iMEF stably expressing m152 or the corresponding
control cells (Fig EV2C). These data, in agreement with our live cell
imaging results, indicate that m152 is not completely blocking STING-
dependent signaling, but is rather delaying the translocation of STING
to the perinuclear region and therefore delaying type I IFN induction.
MCMV lacking m152 induces an elevated type I IFN response
leading to control of viral transcription in vitro
So far, we have shown that ectopically expressed m152 inhibits the
STING-dependent type I IFN response. Next, we wanted to assess
whether m152 targets STING signaling in the context of MCMV
infection. The Ly49H activating receptor on the cell surface of an
NK cell subset from C57BL/6 mice plays a key role in early resis-
tance to MCMV infection (Arase et al, 2002). To prevent interfer-
ence or possible masking of the effect of m152 by highly activated
NK cells in in vivo experiments, we conducted our studies with an
MCMV mutant lacking the interaction partner of Ly49H, m157, here-
inafter referred to as parental MCMV. On this background, we intro-
duced a stop cassette in the m152 ORF to generate the recombinant
MCMV m152stop (Fig 6A). We confirmed the intended mutagenesis
as the m152 protein was only detected in iMEF upon infection with
parental MCMV, but not MCMV m152stop, while expression of the
immediate-early protein IE1 was comparable (Fig 6B). Additionally,
we observed that the m152 protein is synthesized de novo very early
during MCMV infection (Fig EV3A).
Since we have shown that ectopically expressed m152 interacts
with STING (Fig 2D), we next examined whether this interaction is
preserved during MCMV infection. We infected iMEF with parental
MCMV or MCMV m152stop and iMEFgt/gt with parental MCMV
alone and immunoprecipitated m152 (Fig 6C). Endogenous STING
was detected in immunoprecipitates of parental MCMV-infected
iMEF, but not in MCMV m152stop-infected iMEF (Fig 6C), demon-
strating that m152 and STING interact during MCMV infection. To
assess whether m152 inhibits type I IFN responses upon MCMV
infection, we infected primary BMDM with parental MCMV or
MCMV m152stop and observed that infection with MCMV m152stop
led to higher levels of secreted IFNa and IFNb compared to parental
MCMV (Fig 6D). Additionally, via live cell imaging as described
above, we observed that upon infection of iMEFgt/gt Cherry-STING
with parental MCMV, which expresses m152, STING was translo-
cated in significantly fewer cells compared to infection with MCMV
m152stop, which does not express the m152 protein (Fig 6E, repre-
sentative images are shown in Fig EV3B). In agreement with these
results, phosphorylation of TBK1, IRF3, and STING is delayed upon
infection of iMEFs with the parental MCMV compared to infection
with MCMV m152stop (Fig EV3C).
Next, we sought to determine whether modulation of the type I
IFN response by m152 impacts MCMV transcription. Since type I
IFN levels are higher in the absence of m152, we would expect
reduced transcription of viral genes. To test this, we infected iMEF
with parental MCMV or MCMV m152stop and analyzed the
◀ Figure 4. Binding of m152 to both ER-luminal loop regions of murine STING is a prerequisite for its antagonistic activity.A 293T cells were co-transfected with expression plasmids for IFNb-Luc, pRL-TK, cGAS-GFP (stimulated), or IRES-GFP (unstimulated) and indicated expression
plasmids together with murine Cherry-STING (left panel) or human STING (right panel). Lysates were analyzed by dual-luciferase assay. Data are combined from
two out of three independent experiments and shown as mean  SD.
B Schematic representation of the predicted m152 (red) and STING (gray) topology in the ER membrane. (1) and (2) specify the ER-luminal loop regions of STING with
the sequence alignments from murine and human STING shown below. In murine STING, N41 in loop (1) was mutated to E41 and loop (2) was exchanged with
loop (2) of human STING (hL2). The resultant constructs were designated mSTING N41E, mSTING hL2, and mSTING N41E-hL2. In human STING, mutations were
introduced vice versa, resulting in hSTING E41N, hSTING mL2, and hSTING E41N-mL2.
C IFNb-Luc, pRL-TK, cGAS-GFP (stimulated), or IRES-GFP (unstimulated) and either LacZ or m152 together with the indicated murine STING mutants described in (B)
were transiently expressed in 293T cells. Luciferase activity was measured as described in (A).
D 293T cells were co-transfected with expression plasmids for either LacZ or m152 together with the indicated murine STING mutants described in (B). An anti-V5 IP
was performed, and samples were analyzed by IB with the indicated antibodies.
E, F Luciferase assay (E) and co-IP (F) were performed as described in (C) and (D), respectively, using the indicated human STING mutants in place of the murine STING
mutants described in (B).
Data information: Data in (C) and (E) are normalized to LacZ, combined from three independent experiments and shown as mean  SD. IB shown in (D) and (F) are
representative of three independent experiments. Student’s t-test (unpaired, two-tailed), n.s. not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Source data are available online for this figure.
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Figure 5. m152 antagonizes STING translocation, but not its activation by cGAMP or its dimerization.
A Schematic representation of the key steps in the cGAS-STING signaling pathway.
B 293T cells were co-transfected with expression plasmids for IFNb-Luc, pRL-TK, and either ev or m152. Cells were further co-transfected with either Cherry-STING WT
or the constitutively active Cherry-STING V154M (stimulated) or with IRES-GFP (unstimulated). Data are combined from three independent experiments and shown
as mean  SD.
C iMEF stably expressing ev or m152-V5 were stimulated with 10 lg/ml ISD for the indicated times or left unstimulated (mock). Cell lysates were analyzed by SDS–
PAGE under non-reducing conditions and subjected to IB with the specified antibodies.
D Two representative still images from live cell imaging experiments with iMEFgt/gt stably expressing Cherry-STING transfected with ISD (right panel) or left
unstimulated (left panel). Red circles highlight representative translocated STING in ISD stimulated cells, which is used as an indicator of activation.
E iMEFgt/gt stably expressing Cherry-STING and either ev or m152-V5 were stimulated with ISD. Live cell imaging was performed and STING translocation quantified 120
and 180 min post-stimulation. Data shown are one representative of two independent experiments.
F iMEFgt/gt stably expressing Cherry-STING and V5-tagged m152 or corresponding ev were stimulated with 5 lg/ml ISD for the indicated time or left unstimulated
(mock). Lysates were subjected to IB with the specified antibodies.
Data information: IB shown in (C) and (F) are representative of three and two independent experiments, respectively. Student’s t-test (unpaired, two-tailed), n.s. not
significant, *P < 0.05, ****P < 0.0001.
Source data are available online for this figure.
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Figure 6. MCMV lacking m152 induces an elevated type I IFN response leading to lower levels of viral transcripts in vitro.
A Schematic representation of the recombinant MCMV m152stop virus constructed on the MCMV Dm157 backbone (here referred to as parental MCMV and MCMV
m152stop for simplicity). Shown is the transcriptional coding region of m152. STOP indicates the introduced 16 base pair (bp) stop cassette.
B iMEF were infected by centrifugal enhancement with either parental MCMV (par.) or MCMV m152stop at an MOI of 0.5 or mock infected. Three hours post-
infection (hpi), cells were lysed and subjected to immunoblotting (IB) with the specified antibodies.
C iMEF and iMEFgt/gt were infected by centrifugal enhancement with parental MCMV or MCMV m152stop, or parental MCMV alone, respectively (MOI 0.5). Three hpi
lysates were subjected to an anti-m152 IP, and samples were analyzed by IB with indicated antibodies. IB shown is representative of two independent experiments.
D Primary BMDM were infected with parental MCMV (par.) or MCMV m152stop at an MOI of 0.1 or mock infected. At 16 hpi, secreted levels of IFNa or IFNb were
quantified by ELISA. Data are representative of two independent experiments.
E iMEFgt/gt stably expressing Cherry-STING were infected with parental MCMV or MCMV m152stop (MOI 0.5). Live cell imaging was performed and STING
translocation quantified 120 and 180 min post-stimulation. Data shown are representative of two independent experiments.
F, G iMEF or iMEFgt/gt were infected by centrifugal enhancement with parental MCMV or MCMV m152stop (MOI 0.01). At 6 hpi, total RNA was extracted to determine
MCMV IE1 and MCMV E1 (F), IFNb1 and IL6 (G) transcripts by qRT–PCR. Data shown are combined from two out of three independent experiments.
H 293T cells were co-transfected with Cherry-STING, the pNF-jB luciferase reporter, pRL-TK, cGAS-GFP (stimulated), or IRES-GFP (unstimulated) and either ev or
m152. Cells were lysed and analyzed as described in Fig 1. Data are combined from three independent experiments.
Data information: Student’s t-test (unpaired, two-tailed), n.s. not significant, *P < 0.05, **P < 0.01. Data are shown as mean  SD.
Source data are available online for this figure.
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transcript levels of MCMV genes IE1 and E1 6 hours post-infection
(hpi) (Fig 6F). In the absence of m152, reduced IE1 and E1 tran-
script levels were detected, indicating that m152-mediated inhibition
of STING is required for efficient viral transcription at this early
stage of MCMV infection. As a control, m152 transcripts in parental
MCMV-infected cells were present at comparable levels 6 hpi in
STING-proficient and STING-deficient cells (Fig EV3D). To show
that MCMV transcription is affected by m152-mediated inhibition of
STING-dependent IFN signaling, we included STING-deficient MEFs,
iMEFgt/gt in this experiment. In iMEFgt/gt, IE1 and E1 transcript
levels were identical upon both parental MCMV and MCMV
m152stop infection (Fig 6F), demonstrating that the effect on
MCMV transcription exerted by m152 is ameliorated in the absence
of STING. Unexpectedly, we observed that viral transcript levels
were not elevated in iMEFgt/gt (Fig 6F) as it would be expected if
STING had a solely antiviral role. Next, we examined cytokine
levels by measuring IFNb1 and IL6 mRNA transcript levels in iMEF
and iMEFgt/gt infected with parental MCMV or MCMV m152stop
(Fig 6G). As observed in iBMDM, IFNb1 mRNA levels were elevated
in iMEF infected with MCMV m152stop, and as expected, no induc-
tion of IFNb1 was detectable in the absence of STING (Fig 6G).
Additionally, IL6 mRNA induction, which is mediated by NF-jB,
was completely dependent on STING (Fig 6G). This result may shed
a light on our observation that the absence of STING did not elevate
viral transcript levels (Fig 6F), since it has been shown that NF-jB
signaling is crucial for early MCMV replication (Isern et al, 2011).
Notably, IL6 mRNA levels in iMEF were not affected by m152,
which suggests that m152 specifically targets STING-dependent
IRF3, but not NF-jB signaling. Indeed, m152 did not affect activa-
tion of NF-jB-mediated transcription upon cGAS-STING expression
in a luciferase reporter assay (Fig 6H).
So far, our experiments have been conducted in cells derived
from B6J mice. Previously, m152 has been described to prevent cell
surface expression of the NKG2D ligands RAE-1a/b/c (Lodoen et al,
2003), which are expressed in Balb/c, but not in B6J mice. To
exclude competition between STING and these NKG2D ligands, we
infected primary MEFs from B6J and Balb/c mice in parallel with
wild-type MCMV (MW97.01) (Wagner et al, 1999) or the previously
characterized m152 deletion mutant MCMV Dm152 (Wagner et al,
2002), and assessed cytokine expression. As in B6J MEFs, we
observed that m152 inhibits IFNb1, but not IL6 transcription in
Balb/c MEFs (Fig EV4A).
Taken together, these results show that m152 inhibits the STING-
mediated type I IFN response upon MCMV infection in vitro, leading
to reduced type I IFN secretion and increased viral transcription,
while STING-dependent NF-jB activation and IL-6 induction are not
affected by m152.
Reduced transcription of MCMV lacking m152 in vivo is mediated
by STING-dependent signaling
We next addressed the question if the inhibitory effect of m152 on
the type I IFN response and subsequent viral transcription is
preserved in vivo. B6J or STING/ mice were infected with parental
MCMV or MCMV m152stop and type I IFN levels were analyzed in
spleen homogenates and serum 6 hpi (Fig 7A and B). We observed
significantly elevated IFNa and IFNb levels in the spleen and serum
of B6J mice infected with MCMV m152stop compared to infection
with parental MCMV (Fig 7A and B). Consistent with previous obser-
vations that STING-dependent signaling is crucial for the induction of
the initial type I IFN response against MCMV infection (Lio et al,
2016), IFNa was barely detectable in STING/ mice, and IFNb levels
were below the detection limit (Fig 7A and B). Remarkably, the levels
of the NF-jB-induced proinflammatory cytokine IL-6 were not
affected by the presence of m152 in B6J mice (Fig 7C) as observed
in vitro (Fig 6G). STING/ mice did not mount an IL-6 response
(Fig 7C), as observed previously in in vitro settings (Fig 6G), showing
that STING is essential for this early IL-6 response to MCMV infec-
tion. These results confirm our in vitro findings that m152 selectively
inhibits IRF3-mediated activation of type I IFN transcription, but not
NF-jB-mediated IL-6 transcription.
To examine whether the inhibition of type I IFN signaling by
m152 is crucial for MCMV infection in its host, we examined viral
transcript levels upon infection with parental MCMV or MCMV
m152stop. Consistent with our observations in vitro (Fig 6F),
MCMV IE1 and E1 transcripts were significantly reduced in B6J mice
infected with MCMV m152stop compared to infection with parental
MCMV 6 hpi (Fig 7D). Importantly, this suppression in MCMV tran-
scription was rescued in mice lacking STING (Fig 7D), showing that
decreased viral transcription in the absence of m152 is mediated by
STING-dependent signaling. In addition, when we infected Balb/c
mice with wild-type MCMV (MW97.01) or Dm152 MCMV, we
observed similar trends for IFNa and IL-6 levels (Fig EV4B) as well
as MCMV IE1 and E1 transcription (Fig EV4C) as for parental
MCMV and MCMV m152stop in B6J mice (Fig 7A–D).
To address the possibility of cross interference between the
previously characterized inhibitory effect of m152 on very early NK
cell responses and the STING-mediated type I IFN response, we
depleted B6J or STING/ mice of NK cells prior to infection with
parental MCMV or MCMV m152stop for assessment of MCMV tran-
scription (Fig 7F). As we observed comparable results in the pres-
ence or absence of NK cells, we conclude that the effect of m152 on
STING-dependent signaling is independent of its effect on the NK
cell responses. Notably, similar to our observations in MCMV-
infected iMEF (Fig 6F), MCMV IE1, E1, and m152 transcript levels
of parental MCMV and MCMV m152stop were comparable or even
reduced in STING/ mice (Fig 7D–F). This reveals a potentially
dual role for STING, whereby it serves to both restrict and promote
MCMV infection in vivo.
STING activates NF-jB signaling from the ER
Taken together, our results have so far shown that m152 delays
the translocation of STING upon stimulation, thereby inhibiting
the type I IFN response in vitro and in vivo. Interestingly, MCMV
transcript levels were not elevated at early stages of infection in
the absence of STING (Figs 6F and 7D), as would be expected if
STING acts solely as a viral restriction factor. This raised the ques-
tion of whether STING’s role during MCMV infection is exclusively
antiviral. Moreover, we observed that the NF-jB response remains
intact in the presence of m152 (Fig 6H). We therefore hypothe-
sized that STING may activate NF-jB signaling before translocating
from the ER to the Golgi compartment and that this STING-depen-
dent NF-jB response may be beneficial for early MCMV transcrip-
tion. To test this, we screened for a STING mutant which remains
in the ER upon stimulation, and consequently does not induce a
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Figure 7. In the absence of STING, the impairment of MCMV m152stop in vivo is rescued.
A–C Type I IFN levels in spleen homogenates (A) and serum (B) and IL-6 levels in spleen homogenates (C) of C57BL/6J (B6J) or STING/ mice following i.v. infection with
4 × 105 PFU parental MCMV or MCMV m152stop were analyzed 6 hpi by ELISA. IFNb levels of STING/ mice were below the detection limit (n.d.).
D B6J or STING/ mice were i.v. infected with 4 × 105 PFU parental MCMV or MCMV m152stop. Six hpi, RNA was extracted from spleen homogenates and expression
of MCMV IE1 and E1 transcripts was determined by qRT–PCR.
E B6J or STING/ mice were i.v. infected with 4 × 105 PFU parental MCMV. Six hpi, RNA was extracted from spleen homogenates and m152 transcript levels were
determined by qRT–PCR.
F B6J or STING/ mice were depleted of NK cells via treatment with anti-NK1.1 (right panel) or left untreated (left panel). One day after NK cell depletion, B6J or
STING/ mice were i.v. infected with 4 × 105 PFU parental MCMV or MCMV m152stop. Sixteen hpi, RNA was extracted from spleen homogenates and MCMV E1
transcript levels were determined by qRT–PCR. Data were normalized to 107 cellular b-actin transcripts (D–F).
Data information: n = 5–6 mice per group; Student’s t-test (unpaired, two-tailed), n.s. not significant, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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type I IFN response. For human STING, it was previously shown
that ubiquitination is a prerequisite for STING translocation (Ni
et al, 2017). We therefore mutated several lysine residues to argi-
nine in the cytosolic domain of murine STING and performed a
cGAS-STING luciferase assay using luciferase reporters responding
to IRF- and NF-jB signaling (p125 luciferase), to IRF signaling only
(p125AA luciferase), or to NF-jB signaling only (NF-jB luciferase)
(Appendix Fig S4). Most mutations (K83R, K235R, K275R, K337R)
did not alter the capacity of STING to induce IRF- and NF-jB
signaling. In contrast, the K288R STING mutant showed strongly
impaired activation of both IRF-responsive reporters (p55-CIB luci-
ferase and p125AA luciferase), while it was only slightly impaired
in its capability to activate NF-jB-dependent reporters (NF-jB luci-
ferase and p125 luciferase) (Fig 8A). When expressed in 293T
cells, the K288R STING mutant remained in the ER upon stimula-
tion, while WT STING translocated to the perinuclear region
(Fig 8B). These results show that despite remaining in the ER upon
stimulation, the K288R STING mutant can still mount an NF-jB
response. To verify this, we transduced iMEFgt/gt stably expressing
m152-V5 or corresponding control cells with either Cherry-tagged
WT STING or K288R STING and assessed cytokine expression. As
shown before, upon stimulation with ISD, WT STING induced the
transcription of IFNb1 and IL6 mRNA, and the presence of m152
inhibited the induction of IFNb1, but not IL6 mRNA (Fig 8C and D).
In agreement with our luciferase reporter and IF assays, STING
K288R could not induce the transcription of IFNb1 mRNA, however,
induction of IL6 transcription was preserved (Fig 8C and D). In
addition, iMEFgt/gt stably expressing Cherry-tagged K288R STING
induced NF-jB (p65) nuclear translocation upon MCMV infection as
well as iMEFgt/gt stably expressing Cherry-tagged WT STING, while
no p65 nuclear translocation was observed in iMEFgt/gt lacking
STING expression (Fig EV5). As shown in Fig EV2B, STING translo-
cation is crucial to activate the kinase TBK1. To evaluate whether
TBK1 is needed for STING-dependent NF-jB activation, we
performed an siRNA-mediated knockdown of TBK1 in 293T cells
(Appendix Fig S5A) and performed a cGAS-STING luciferase assay
with IRF and NF-jB response reporter constructs. While WT STING
and K288R STING did not activate the IRF-responsive p55-CIB luci-
ferase reporter in TBK1 knockdown cells, activation of the NF-jB
response luciferase reporter was similar in TBK1-proficient and
TBK1-deficient cells (Appendix Fig S5B). Taken together, these
results show that STING activates NF-jB-dependent signaling at the
ER independent of the kinase TBK1.
STING-mediated NF-jB activation promotes early
MCMV transcription
With the K288R STING mutant, we could now distinctly dissect the
NF-jB and IRF arms of STING signaling as well as test our hypothe-
sis that STING-mediated NF-jB activation promotes MCMV tran-
scription. While MCMV infection of cells expressing WT STING will
mount both an NF-jB and IRF response, infection of K288R STING
expressing cells only results in an NF-jB response. We infected
iMEFgt/gt, iMEFgt/gt stably expressing Cherry-tagged WT STING, or
K288R STING with the parental MCMV and MCMV m152stop and
analyzed viral transcript levels (Fig 8E). As shown earlier (Fig 6F),
MCMV E1 transcript levels were not affected by the presence of
m152 in iMEFgt/gt, while infection of WT STING expressing cells
with MCMV m152stop led to reduced MCMV E1 transcript levels
compared to infection with parental MCMV (Fig 8E). In agreement
with our findings that m152 targets STING trafficking, the presence
of m152 did not affect viral transcription in cells expressing the
K288R STING mutant, since this mutant does not translocate upon
activation (Fig 8E).
Notably, in the presence of K288R STING, which only activates
NF-jB, but not IRF, signaling viral transcript levels upon infection
with MCMV m152stop were significantly higher compared to
iMEFgt/gt, in which the type I IFN response is completely abrogated,
and in iMEFgt/gt stably expressing WT STING, which can mount an
IRF response unaffected by m152 (Fig 8E).
Moreover, we observed that the viral transcript levels upon infec-
tion with the parental MCMV are significantly higher in cells stably
expressing either WT STING or K288R STING compared to iMEFgt/gt
(Fig 8E). This shows that parental MCMV also benefits from the
presence of STING, which is contrary to the current paradigm of
STING acting solely as a restriction factor for MCMV.
As mentioned before, both K288R STING and WT STING activate
NF-jB signaling, whereas only WT STING additionally induces the
antiviral type I IFN response. Our data clearly suggest that MCMV
evolved the m152 protein to modulate the STING-mediated type I
IFN response, while leaving the NF-jB response untouched. Hence,
viral transcript levels in WT STING and K288R STING expressing
cells are expected to be comparable in the presence of m152.
Indeed, when we infected WT or K288R STING expressing cells with
parental MCMV (which expresses m152), we do not observe a
significant increase in viral transcript levels. This once again shows
that MCMV profits from intact STING-mediated NF-jB signaling.
Taken together, our study identifies MCMV m152 as a novel viral
antagonist of the STING-mediated antiviral type I IFN response and
reveals that STING activates NF-jB signaling already from the ER
prior to trafficking to the Golgi which is beneficial for early MCMV
transcription.
Discussion
The cGAS-STING signaling pathway plays a pivotal role in the
antiviral innate immune response with the number of corresponding
viral antagonists rising steadily. While some herpesviral antagonists
target cGAS directly (Wu et al, 2015; Zhang et al, 2016; Su & Zheng,
2017), others mediate the degradation of STING (Kim et al, 2017) or
target downstream signaling pathways (Christensen et al, 2016).
However, the m152 protein is a clear stand out: It modulates this
pathway differentially by antagonizing cGAS-STING-mediated acti-
vation of type I IFN signaling, while leaving cGAS-STING-mediated
activation of NF-jB signaling intact, and it does so by delaying traf-
ficking of STING from the ER to the Golgi compartment (Fig 9).
Through our detailed mechanistic study of this novel and selective
STING modulator, we have uncovered that STING activates NF-jB
signaling already from the ER, prior to its trafficking (Fig 9).
Furthermore, our study is the first to show the necessity of STING-
mediated NF-jB signaling for CMV transcription in vitro, as well as
the necessity of modulation of the STING-mediated type I IFN
response for CMV replication in vitro and in vivo.
We have shown that the m152 protein co-localizes and interacts
with STING in unstimulated cells in the ER and likewise traffics with
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Figure 8. The STING-mediated NF-jB response is activated from the ER and specifically pro-viral for MCMV transcription.
A 293T cells were co-transfected with Cherry-STING, pRL-TK, cGAS-GFP (stimulated), or IRES-GFP (unstimulated) and either the pNF-jB, p55-CIB, p125, or p125AA
luciferase reporter. Data are representative of two independent experiments.
B 293T cells were co-transfected with expression plasmids for cGAS-GFP (stimulated) or ev (unstimulated) together with either cherry-tagged WT STING or cherry-
tagged K288R STING. Cells were fixed for imaging 24 h post-transfection. Scale bar represents 10 lm.
C, D iMEFgt/gt stably expressing cherry-tagged WT STING or K288R STING and either ev or V5-tagged m152 were stimulated with ISD (10 lg/ml) or mock stimulated. At
4 hpi, total RNA was extracted to determine IFNb1 (C) and IL6 (D) transcripts by qRT–PCR. Data shown are combined from three (C) or two (D) out of three
independent experiments.
E iMEFgt/gt (-) and iMEFgt/gt stably expressing either cherry-tagged WT STING or K288R STING were infected by centrifugal enhancement with parental MCMV or
MCMV m152stop (MOI 0.01). Six hpi total RNA was extracted to determine MCMV E1 transcripts by qRT–PCR. Data shown are combined from three independent
experiments.
Data information: Student’s t-test (unpaired, two-tailed), n.s. not significant, *P < 0.05, **P < 0.01, ****P < 0.0001. Data are shown as mean  SD.
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STING to the Golgi compartment in stimulated cells (Fig 2). Exempli-
fying the strict host specificity and the host adaptation of CMVs,
m152 interacts with murine, but not human STING. Using targeted
chimeras, we could show that this interaction is directed by the N-
terminal domain of m152 and the two ER-luminal loop regions of
STING (Figs 3 and 4). Upon dissection of the STING signaling path-
way, we show that m152 has no effect on STING activation by
cGAMP or on STING dimerization, but delays its translocation from
the ER to the Golgi compartment, which we show by ectopic expres-
sion of m152 and in the context of MCMV infection (Fig 5). The delay
in STING trafficking mediated by m152 specifically resulted in inhibi-
tion of the type I IFN response, which is initiated by STING via TBK1
and IRF3 from the Golgi compartment and requires STING transloca-
tion. On the contrary, the STING-dependent NF-jB response was not
inhibited by m152. While infection with an MCMV lacking m152
induced elevated type I IFN responses both in vitro and in vivo, lead-
ing to tighter host control of viral transcription at early time points
post-infection, the NF-jB-dependent IL-6 response was not affected
by m152 (Figs 6 and 7). Taken together, these results suggested that
murine STING may activate the NF-jB pathway already at an earlier
stage, probably at the ER membrane, prior to its trafficking to the
Golgi compartment (Fig 9). Based on this hypothesis, we generated
and characterized the STING mutant K288R, which remains ER-bound
and can therefore not induce type I IFN signaling. We could show that
the STING K288R mutant was indeed still able to induce an NF-jB
response similar to WT STING (Fig 8). This finding is in line with a
previous study showing that the human STING mutant K224R is
translocation-deficient, but can still trigger NF-jB signaling upon stim-
ulation (Ni et al, 2017). However, the corresponding mutation of
K288R in human STING, K289R, was reported to lead to a hyper-
active version of human STING (Ni et al, 2017).
Interestingly, although we expected strongly enhanced MCMV
transcription in the absence of STING, since it is a major host
restriction factor of MCMV, we observed slightly reduced viral tran-
script levels in STING/ mice (Fig 7). Notably, we observed that
NF-jB-dependent IL-6 induction, as well as IRF3-dependent type I
IFN induction, is completely dependent on STING in vitro and
in vivo at this early stage of MCMV infection (Figs 6 and 7). Studies
with the HCMV major immediately early promoter (MIEP) enhancer
have shown that NF-jB interaction with corresponding binding sites
in the enhancer element is essential for MIEP activity and initiation
of the viral transcriptional program (Caposio et al, 2007). In addi-
tion, it has been shown that a combinatorial knockout of NF-jB and
AP-1 sites in the MCMV MIEP enhancer leads to reduced MCMV
replication (Isern et al, 2011). To show whether STING-mediated
activation of NF-jB is indeed required for initial MCMV replication,
we complemented STING-deficient murine fibroblasts with the
STING K288R mutant and found enhanced MCMV transcript levels
compared to cells lacking STING signaling (Fig 8), strongly suggest-
ing that the STING-mediated NF-jB response is specifically pro-
viral. Hence, our findings reveal a dual role for STING, whereby it
serves to both restrict and promote MCMV infection in vivo.
The m152 protein has an impressive immune evasion repertoire.
m152 has previously been described to evade NK cell- and T cell-
dependent immune responses (Krmpotic et al, 2002; Fink et al,
2013). m152 prevents cell surface expression of the NKG2D ligands
RAE-1a/b/c/d/e (Lodoen et al, 2003), and for RAE-1c and RAE-1e,
it was demonstrated that m152 retains these molecules in the
A B
Figure 9. The multifaceted m152 protein selectively modulates STING-dependent type I IFN, but not NF-jB, signaling.
A Upon stimulation with DNA or by viral infection, the pattern recognition receptor (PRR) cGAS produces the second messenger 2030-cGAMP, which binds to the ER-
resident protein STING. STING then dimerizes and translocates from the ER to the Golgi, from where it activates the signaling pathway leading to induction of type I
IFN via the kinase TBK1 and the IRF3 transcription factor. cGAS-STING signaling also induces activation of the NF-jB transcription factor, leading to proinflammatory
cytokine expression, but from which subcellular compartment this signaling pathway is initiated is not understood.
B The viral type I membrane protein m152 is expressed immediately after MCMV infection. m152 binds STING in the ER via their respective luminal domains and
traffics with STING to the Golgi. In the presence of m152, trafficking of STING is delayed, leading to a reduced type I IFN, but intact NF-jB, response. Mutation of K288
in STING results in a STING mutant that cannot leave the ER and thereby cannot activate the type I IFN response, but is still able to induce the NF-jB pathway.
These results suggest that STING induces the NF-jB pathway from the ER, prior to its trafficking to the Golgi.
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ERGIC, presumably by direct interaction (Arapovic et al, 2009a,b;
Wang et al, 2012). In addition, m152 was described as a modulator
of antigen presentation to CD8 T cells (Ziegler et al, 1997; Krmpotic
et al, 1999). m152 retains peptide-loaded MHC class I molecules in
the ERGIC, thereby preventing MHC class I surface expression
(Ziegler et al, 1997; Lemmermann et al, 2010). These findings raise
the question of whether the effect of m152 on STING, MHC class I,
and RAE-1 proteins may be linked with each other. The m152-
mediated delay in STING trafficking is most likely independent of its
interaction with MHC class I, since we show that the m152 stalk
region is dispensable for its interaction with STING and downmodu-
lation of STING-mediated type I IFN signaling (Fig 3), whereas the
stalk region is required for the interaction between m152 and MHC
class I (Janssen et al, 2016). In addition, the effect m152 exerts on
the STING-mediated type I IFN response occurs at a very early stage
of MCMV infection, while the CD8 T cell response follows days
later. Our NK cell depletion experiments clearly show that the
reduced transcriptional activity of MCMV m152stop at 16 hpi is not
attributed to the NK cell response, nor is it a result of the inhibitory
effect of m152 on NK cell activation, but is solely due to the interac-
tion between m152 and STING (Fig 7). In addition, the RAE-1
ligands that are downregulated most efficiently by m152, RAE-1a/b/
c (Lodoen et al, 2003), are not present in B6J mice (Lodoen et al,
2003; Arapovic et al, 2009b), in which most of our experiments
have been conducted. This together with our NK cell depletion data
in vivo clearly shows that m152 modulates the STING-mediated type
I IFN response independently of its effect on RAE-1.
It is fascinating how many strategies MCMV has evolved to inhibit
PRR signaling: The M27 protein inhibits signaling downstream of the
IFNAR (Zimmermann et al, 2005). Notably, the tegument protein
M45 first activates NF-jB signaling immediately upon MCMV infec-
tion (Krause et al, 2014), whereas de novo expressed M45, which is
expressed later than m152, shuts down the proinflammatory cytokine
response downstream of TLR signaling (Fliss et al, 2012). We have
shown that the tegument protein M35 greatly reduces NF-jB-mediated
transcription of IFNb downstream of multiple PRR (Chan et al, 2017).
This shows how precisely MCMV modulates the innate immune
response, always adjusted to its needs and according to the stage of
viral replication. We have now expanded on the scope and intricacies
of the immune modulation mechanisms employed by MCMV to
subvert multiple facets of the host immune defense via a single multi-
functional immune evasion protein. In addition, the delay in STING-
dependent type I IFN signaling, but not NF-jB signaling, provides a
crucial advantage for MCMV in the establishment of an infection. In
addition, m152 has provided us with novel insights into the precise
steps of the crucial STING signaling pathway. By dissecting the
immune evasion strategies exerted by MCMV m152, it becomes
apparent that CMV has evolved elegant ways to not only modulate
immune detection, but also actively manipulate and balance host
responses to create an optimal environment for infection.
Materials and Methods
Ethics statement
All animal experiments were performed in compliance with the
German animal protection law (TierSchG BGBI S. 1105;
25.05.1998). The mice were handled in accordance with good
animal practice as defined by FELASA and GV-SOLAS. All animal
experiments were approved by the responsible state office (Lower
Saxony State Office of Consumer Protection and Food Safety) under
permit numbers #33.9-42502-04-12/0930 and #33.19-42502-04-17/
2657. For NK cell depletion experiments, all animals were housed
and bred under specific pathogen–free conditions at the Central
Animal Facility, Faculty of Medicine, University of Rijeka, Croatia,
in accordance with the guidelines contained in the International
Guiding Principles for Biomedical Research Involving Animals. The
Ethics Committee at the University of Rijeka and National ethics
committee approved all animal experiments.
Mice
Mice used at the animal facility of the Helmholtz Centre for Infection
Research in Braunschweig, Germany, and at the Central Animal Facility,
Faculty of Medicine, University of Rijeka, Croatia, were bred and main-
tained under specific pathogen-free conditions. STING knockout
(MPYS//Tmem173tm1.2Camb) and goldenticket (C57BL/6J-Tmem173gt)
mice have been described (Jin et al, 2011; Sauer et al, 2011).
C57BL/6J (B6J) or STING/ mice were infected by the intra-
venous route with 4 × 105 PFU. Balb/c mice were infected by the
intravenous route with 1 × 106 PFU. Six hpi serum and spleen were
collected and analyzed for cytokines and viral transcripts.
NK cells were depleted from B6J or STING/ mice with a-NK1.1
(clone PK136, 250 lg per mouse, intraperitoneal route) 1 day prior
infection. Efficacy of NK cell depletion was analyzed by cytofluoromet-
ric analysis 1 day after depletion. Mice were then infected with MCMV
as described above and spleen and serum were collected 16 hpi.
Viruses
Manipulation of the MCMV genome was carried out by en passant
mutagenesis (Tischer et al, 2010) on the MCK-2 repaired MCMV
BAC-plasmid (Jordan et al, 2011) in which the m157 ORF has been
deleted (Dm157). pEP-KanS (Tischer et al, 2010) served as the
template for PCR. For construction of the recombinant MCMV-
m152stop, a linear PCR product was generated using primers
m152STOPEPfor: 50-CTACTTGCTCCTCTCGGTTC TCATAAACCGA
GGCGAGACGGGCTAGTTAACTAGCCGCGGGCAGCAGCTATATGGA
AGGATGACGACGATAAGTAGGG-30 and m152STOPEPrev: 50-
CATCCTCGAATATGCGCACGTCCATATAGCTGCTGCCCGCGGCTAG
TTAACTAGCCCGTCTCGCCTCGGTTTATGACAACCAATTAACCAAT
TCTGATTA-30 to introduce a stop cassette (bold) between nucleo-
tide positions 211,421 and 211,422 (accession #GU305914). MCMV-
specific sequences are underlined. The recombinant MCMV BAC
m152stop was fully sequenced by pair-end sequencing using the
MiSeq System (Illumina) to verify that no errors were introduced
compared to MCMV BAC Dm157. Recombinant MCMV BACs were
reconstituted and high titer virus stocks prepared as described previ-
ously (Chan et al, 2017). Unless otherwise stated, MCMV Dm157 is
designated as parental MCMV. Balb/c mice were infected with
MW97.01 (Wagner et al, 1999) and the corresponding Dm152
MCMV (Wagner et al, 2002).
Newcastle disease virus (NDV) was kindly provided by Andrea
Kro¨ger (Helmholtz Centre for Infection Research, Braunschweig,
Germany).
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Cell lines
M2-10B4 (CRL-1972), HeLa S3 (CCL-2.2), and human embryonic
kidney 293-T/17 cells (293T, CRL-11268) were obtained from ATCC.
293T and M2-10B4 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM; high glucose) supplemented with 8% fetal
calf serum (FCS), 2 mM glutamine (Gln), and 1% penicillin/strepto-
mycin (P/S). HeLa S3 were cultured using the same medium
described above, supplemented with 1% non-essential amino acids
(NEAA) and 1 mM sodium pyruvate.
Primary B6J wild-type (WT) mouse embryonic fibroblasts (MEF)
and goldenticket MEF (MEFgt/gt) were immortalized by SV40 LT
antigen. The immortalized murine bone marrow-derived macro-
phage (iBMDM) cell line was obtained through BEI Resources,
NIAID NIH (NR-9456). iBMDM were maintained in DMEM supple-
mented with 8% FCS, 2 mM Gln, 1% P/S, and 50 lM b-mercap-
toethanol. iMEF were maintained in the same medium as iBMDM
with additional 1% NEAA. iBMDM and iMEF stably expressing
empty vector (ev) or m152-V5/His were generated by retroviral
transduction using the constructs pMSCVpuro and pMSCVpuro
m152-V5/His and selection with 10 lg/ml puromycin. iMEFgt/gt
stably expressing cherry-tagged WT STING or K288R STING were
generated by retroviral transduction and sorted by FACS to select
for Cherry-positive cells. For generation of iMEFgt/gt expressing
Cherry-STING and either ev or m152-V5/His, iMEFgt/gt Cherry-
STING were transduced with pMSCVpuro or pMSCVpuro m152-V5/
His, respectively, and selection was carried out as described above.
Primary cells
For generation of primary bone marrow-derived macrophages, bone
marrow was extracted from wild-type B6J mice and cells were
cultured in DMEM (high glucose) supplemented with 10% FCS,
2 mM Gln, 1% P/S, 50 lM b-mercaptoethanol, and 5% macrophage
colony-stimulating factor (MCSF) as described previously (Bussey
et al, 2014). Primary mouse embryonic fibroblasts from B6J and
Balb/c mice were generated by standard protocol.
Plasmids
Expression constructs for m152-V5/His, M35-V5/His, LacZ-V5/His,
and M27-V5/His (all in pcDNA3.1-V5/His, Invitrogen) have been
described previously (Munks et al, 2006). pBS-mCD4 was
purchased from Addgene (#14613) and subcloned into pcDNA3.1-
V5/His via the HindIII/BstXI sites to generate pcDNA3.1 mCD4-V5/
His. pcDNA4 ORF36-myc/His was previously described (Bussey
et al, 2014) and codes for ORF36 of Kaposi’s sarcoma-associated
herpesvirus (KSHV). pPolI A/California/04/2009 NS was kindly
provided by Toru Takimoto (University of Rochester Medical
Center, USA) and subcloned into pcDNA3.1(-) via the NotI/EcoRI
sites to generate pcDNA3.1(-) Cal NS1.
pEFBOS mCherry-mSTING (designated Cherry-STING) express-
ing monomeric Cherry fused to the N terminus of murine STING
and pIRESneo3 cGAS-GFP (GFP fused to the C terminus of human
cGAS) were kindly provided by Andrea Ablasser (Global Health
Institute, Ecole Polytechnique Fe´de´rale de Lausanne, Switzerland).
pcDNA3 hSTING coding for untagged human STING was described
previously (Christensen et al, 2016). pRL-TK, which expresses
Renilla luciferase under control of the thymidine kinase promoter,
and pIRES2-GFP were purchased from Promega and Clontech,
respectively. pNF-jB Luc, containing five NF-jB responsive elements
(TGGGGACTTTCCGC) upstream of the firefly luciferase gene, is
commercially available from Agilent Technologies. pGL3basic IFNb-
Luc (IFNb-Luc) and pGL3basic ISG56-Luc (ISG56-Luc) were described
previously (Chan et al, 2017). The firefly luciferase reporter plasmids
p125, consisting of the human IFNb promoter region (125 to +19), its
related mutant p125AA Luc (CC to AA, 58) with disrupted NF-jB
binding, and p55-CIB, containing 8 tandem repeat motifs (AAGTGA)
corresponding to 7 repeats of an IRF binding element (AANNGAAA),
were kindly provided by Takashi Fujita (Kyoto University, Japan)
(Fujita et al, 1989; Yoneyama et al, 1996). pcDNA3-FLAG-TBK1 was
described previously (Christensen et al, 2016). CMVBL IRF3-5D codes
for human IRF3 containing five amino acid substitutions (S396D,
S398D, S402D, S404D, S405D) which render it constitutively active
and was provided by John Hiscott (Institut Pasteur Cenci Bolognetti
Foundation, Rome, Italy). pCAGGS Flag-RIG-I N, expressing a constitu-
tively active truncation mutant of RIG-I, was kindly provided by
Andreas Pichlmair (Technical University Munich, Germany).
Cherry-STING and m152-V5/His were subcloned into pMSCVpuro
(Clontech) via the BglII/EcoRI sites to generate pMSCVpuro Cherry-
STING and pMSCVpuro m152-V5/His, respectively. pcDNA3.1-
m152-N83Q-N230Q-N263Q (Fink et al, 2013), pSP64-poly(A)-b-actin
(Wilhelmi et al, 2008), pSP64-poly(A)-IE1 (Kurz et al, 1999), and
pDrive-E1 (Simon et al, 2006) were published previously. pSP64-
poly(A)-m152 was generated by subcloning of the PCR amplified
ORF m152 into pSP64-poly(A) via the HindIII/XmaI sites. pcDNA3.1-
m152-N83Q-N230Q-N263Q was subcloned into pcDNA3.1-V5/His via
the BamHI/BstXI sites to generate pcDNA3.1m152- N83Q-N230Q-
N263Q-V5/His.
The following constructs were cloned using the Q5 site-directed
mutagenesis kit (NEB #E0554) according to the manufacturer’s
protocol: pcDNA3.1m152-DCTD-V5/His was generated by deletion
of the last 23 amino acids (aa) of the C terminus of m152 (accession
#GU305914, region 210342-211478). For construction of pcDNA3.
1m152-CD4CTD-V5/His, the last 25 aa of m152 were replaced
with the 33 C-terminal aa of murine CD4 (mCD4, accession
#NM_013488.2). pcDNA3.1m152-CD4TM-V5/His was generated by
replacing aa 327–352 of m152 with aa 395–419 of mCD4.
pcDNA3.1m152-CD4TMCTD-V5/His was constructed by exchanging
aa 327–378 of m152 with aa 395–457 of mCD4. For pcDNA3.1 CD4-
m152SPCTD-V5/His, aa 1–26 of mCD4 were replaced with aa 1–19 of
m152 and aa 420–457 were replaced by the corresponding sequence
of m152. For pcDNA3.1 CD4-m152SPTMCTD-V5/His, aa 1–26 of
mCD4 were replaced with aa 1–19 of m152 and aa 395–457 were
replaced by the corresponding sequence of m152. pcDNA3.1m152-
Dstalk was generated by deletion of aa 300–326. pcDNA3.1m152-
GSstalk was constructed by replacing aa 300–326 with a glycine-serine
linker (G4S)5. For murine Cherry-STING, the N to E mutation at posi-
tion 41 or the exchange of QNTADIY ? PNAVGPP at position 109–
115 was introduced singly or in combination. Human STING mutants
were generated by introducing the E to N mutation at position 41 or
the PNAVGPP ? QNTADIY aa exchange at position 110–116 singly
or in combination. Constitutively active murine STING was generated
by introducing the mutation V154M. Murine Cherry-STING lysine
mutants were generated by singly introducing the mutations K83R,
K235R, K275R, K288R, or K337R. All constructs were verified by
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sequencing. Primer sequences as well as sequences of all constructs
are available upon request.
Antibodies and reagents
Rabbit anti-STING (#13647, clone D2P2F), rabbit anti-phospho-
TBK1 (#5483, clone D52C2) and rabbit anti-phospho-IRF3 (#4947,
clone 4D4G), anti-p65 (#4764, clone C22B4) antibodies were
purchased from Cell Signaling Technology. Mouse anti-tubulin
(T6199, clone DM1A), mouse anti-actin (A5441, clone AC-15), and
Brefeldin A (B7651) were obtained from Sigma-Aldrich. The mouse
anti-V5 antibody was purchased from Invitrogen (R960-25) and
Biolegend (#680601); the mouse anti-V5 HRP conjugate was from
Invitrogen (R961-25). Mouse antibodies against MCMV IE1 (#HR-
MCMV-08, clone CROMA101) and MCMV m152 (#HR-MCMV-11,
clone m152.05) were generated at the Center for Proteomics
(CapRi), Faculty of Medicine, University of Rijeka. HRP-conjugated
and Alexa Fluor-conjugated secondary antibodies were purchased
from Dianova and Invitrogen, respectively.
2030-cGAMP (#tlrl-nacga23) and high molecular weight poly(I:C)
(#tlrl-pic) were purchased from Invivogen. CpG-B DNA 1826 was
obtained from Eurofins Genomics. Interferon-stimulatory DNA (ISD)
was generated by the combination of complementary forward
(ISD45 bp-for: 50-TACAGATCTACTAGTGATCTATGACTGATCTGTA
CATGATCTACA) and reverse (ISD45 bp-rev: 50-TGTAGATCATGTA
CAGATCAGTCATAGATCACTAGTAGATCTGTA) 45 bp oligonu-
cleotides, heating to 70°C for 10 min followed by annealing at room
temperature. Protease inhibitors (4693116001) and phosphatase
inhibitors (4906837001) were purchased from Roche.
The transfection reagents Lipofectamine 2000, FuGENE HD, and
polyethyleneimine (PEI) were purchased from Life Technologies,
Promega, and Polysciences, Inc., respectively. OptiMEM was
obtained from Thermo Fisher Scientific.
Luciferase-based reporter assays
cGAS-STING: 293T cells (25,000 cells/well, 96-well format) were tran-
siently transfected with 60 ng Cherry-STING, pcDNA3 hSTING, or
STING mutants, 60 ng pIRESneo3 human cGAS-GFP (for stimulated
conditions), 60 ng pIRES2-GFP (for unstimulated conditions), 100 ng
pGL3basic IFNb-Luc, 10 ng pRL-TK, 120 ng plasmid of interest, and
1.2 ll FuGENE HD (Promega) diluted to 10 ll total volume with
OptiMEM. To analyze activation of other luciferase reporters, pGL3ba-
sic-IFNb-Luc was substituted with 50 ng p125, 50 ng p125AA, or 1 ng
of p55-CIB reporter plasmids. For NF-jB Luciferase assays, cells were
transfected with 10 ng pNF-jB Luciferase and 20 ng pRL-TK instead
of 100 ng pGL3basic IFNb-Luc and 10 ng pRL-TK.
RIG-I N: 293T cells (25,000 cells/well, 96-well format) were tran-
siently transfected with 13 ng pCAGGS Flag-RIG-I N (stimulated) or
pcDNA3.1 (unstimulated) together with 50 ng pGL3basic IFNb-Luc,
5 ng pRL-TK, and 130 ng plasmid of interest and 0.66 ll FuGENE
HD (Promega) diluted to 10 ll total volume with OptiMEM.
TBK1 and IRF3-5D: 293T cells (25,000 cells/well, 96-well format)
were transiently transfected with 10 ll of FuGENE HD/DNA
complexes composed of 100 ng pcDNA3-FLAG-TBK1 or CMVBL
IRF3-5D (stimulated) or 100 ng pIRES2-GFP (unstimulated), 100 ng
pGL3basic IFNb-Luc, 10 ng pRL-TK, 120 ng plasmid of interest, and
1 ll FuGENE HD (Promega) diluted in OptiMEM.
For the cGAS-STING, RIG-I N and IRF3-5D luciferase assays cells
were lysed 20 h post-transfection in 1× passive lysis buffer
(Promega).
IFNb stimulation and ISG56 reporter assay: 293T cells (25.000
cells/well, 96-well format) were transiently transfected with 10 ll of
FuGENE HD/DNA mixtures containing 100 ng pGL3basic ISG56-
Luc, 10 ng pRL-TK, 120 ng plasmid of interest, and 0.8 ll FuGENE
HD diluted in OptiMEM. 24 h post-transfection, cells were stimu-
lated by addition of recombinant human IFNb (PeproTech, #300-
02BC) to a concentration of 0.1 ng/ml or were mock stimulated and
lysed 16 h later in 1× passive lysis buffer (Promega).
Luciferase production was measured using the dual-luciferase
assay system (Promega) and either a GloMax 96 Microplate Lumi-
nometer (Promega) or an Infinite M200 PRO plate reader (Tecan).
Luciferase fold induction was calculated by dividing Renilla-normal-
ized values from stimulated samples by the corresponding values
from unstimulated samples.
Quantitative RT-PCR
iMEFgt/gt stably expressing Cherry-STING and either ev or m152-V5
were stimulated by transfection with either 5 lg/ml ISD or 10 lg/ml
poly(I:C) complexed with Lipofectamine, or transfected with Lipofec-
tamine only. 4 hours post-transfection, cells were lysed in RLT buffer
supplemented with b-mercaptoethanol and RNA was purified with
the RNeasy Mini Kit (Qiagen #7410) followed by DNase treatment
(Qiagen #79254) according to the manufacturer’s instructions. For
synthesis of cDNA and quantification of gene transcripts, 100 ng of
RNA was used per sample and quantitative RT-PCR was performed
using the EXPRESS One-Step SuperscriptTM qRT-PCR Kit (Invitrogen
#11781200) on a LightCycler 96 instrument (Roche). Rlp8 served as
the housekeeping control. PCR primers and Universal probe library
(UPL, Roche) probes used were as follows: Rlp8 (Rlp8_for: 50 caaca
gagccgttgttggt, Rlp8_rev: 50 cagcctttaagataggcttgtca, UPL probe 5);
IFNb (IFNb_for: 50 ctggcttccatcatgaacaa, IFNb_rev: 50 agagggctgtggtg
gagaa, UPL probe 18); IL-6 (IL6_for: gctaccaaactggatataatcagga,
IL6_rev: ccaggtagctatggtactccagaa, UPL probe 6).
For the quantification of viral transcripts in the spleen, quantitative
RT-PCR specific for MCMV m123/IE1, MCMV M112/E1, and MCMV
m152 was performed. RNA was extracted from spleen homogenates
using the RNeasy Mini Kit followed by DNase treatment as described
above. Quantitative RT-PCR was performed using the OneStep RT-
PCR Kit (Qiagen #210212) on a LightCycler 96 instrument (Roche).
Absolute quantification of viral transcript numbers was performed
using a dilution series of specific in vitro transcripts as standards. For
normalization, cellular b-actin transcripts were quantified in parallel.
For generation of the dilution series, pSP64 poly(A) b-actin, pSP64
poly(A) IE1, pDrive E1, and pSP64 poly(A) m152 were first linearized
using EcoRI and in vitro transcribed using the MEGAscript T7 Kit
(Thermo Fisher Scientific, #AM1333). The number of generated tran-
scripts was calculated, and a serial dilution of transcripts with
defined, graded amounts per microliter was prepared. PCR primers
and probe (50 6-FAM labeled, 30 black hole quencher (BHQ) labeled)
sequences were as follows: b-actin: b-actin_for: 50 gacggccaggtcatcac
tattg, b-actin_rev: 50 cacaggattccatacccaagaagg, b-actin_probe: 50
aacgagcggttccgatgccc; MCMV IE1: IE1_for: 50 tggctgattgatagttctgttt
tatca, IE1_rev: 50 ctcatggaccgcatcgct, IE1_probe: 50 aacgctcctcact
gcagcatgcttg; MCMV E1: E1_for: 50 tgctcccactgaggaagagaaga, E1_rev:
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50 gaggccgctgctgtaacaat, E1_probe: 50 agcccaagcgccagaagaccca; MCMV
m152: m152_for: 50 cgttcgcgagactgatgttgt, m152_rev: 50 gcaacggctacgt
gtcctgta, m152_probe: 50 ccaacggaacctgagtgcgca.
ELISA
IFNa levels were measured with a rat anti-mouse IFNa capture
antibody (PBL #22100-1) and a rabbit anti-mouse IFNa detection
antibody (PBL #32100-1). IFNb production was detected using the
PBL mouse IFNb ELISA kit (PBL #42400-1) or the LumiKine mouse
IFNb ELISA kit (Invivogen #lumi-mifnb) according to the manufac-
turer’s instructions. The IL-6 ELISA was performed according to
the manufacturer’s protocol (BD Biosciences #555240). TNFa
levels were determined as described previously (Bussey et al,
2014). The preparation of spleens from infected mice for measur-
ing type I IFN levels by ELISA has been described previously
(Chan et al, 2017).
Immunofluorescence
HeLa cells were seeded onto acid-washed coverslips in 24-well
plates. 24 hours later, cells were transiently transfected with
FuGENE HD/DNA complexes composed of 200 ng pEFBOS
mCherry-mSTING, 200 ng pcDNA3.1m152-V5/His, either 150 ng
pIRESneo3 human cGAS-GFP (stimulated) or 150 ng pcDNA3.1 (ev)
(unstimulated) and 1.4 ll FuGENE HD (Promega) diluted in
OptiMEM. iMEFgt/gt were similarly seeded and 24 h later transiently
transfected with FuGENE HD/DNA complexes composed of 200 ng
pcDNA3.1m152-V5/His together with either 200 ng pEFBOS
mCherry-mSTING or 200 ng empty vector in combination with
200 ng pIRESneo3 human cGAS-GFP (stimulated) or 200 ng empty
vector (unstimulated) and 2 ll FuGENE HD (Promega) diluted in
OptiMEM. 293T cells were seeded in 24-well plates and transiently
transfected with FuGENE HD/DNA complexes composed of 150 ng
pEFBOS mCherry-STING, 300 ng V5-tagged CD4, m152, or the
respective m152 mutant, together with either 150 ng pIRESneo3
human cGAS-GFP (stimulated) or 200 ng empty vector (unstimu-
lated) and 2 ll FuGENE HD (Promega). To detect translocation of
Cherry-STING WT or Cherry-STING K288R, 293T cells were trans-
fected with FuGENE HD/DNA complexes composed of 200 ng
pEFBOS mCherry-mSTING WT or pEFBOS mCherry-mSTING K288R
in combination with 200 ng pIRESneo3 human cGAS-GFP (stimu-
lated) or 200 ng empty vector (unstimulated) and 2 ll FuGENE HD
(Promega) diluted in OptiMEM. iMEFgt/gt, iMEFgt/gt stably express-
ing Cherry-STING WT or iMEFgt/gt stably expressing Cherry-STING
K288R were seeded in 24-well plates and either stimulated by trans-
fection with 10 lg/ml poly(I:C) complexed with Lipofectamine or
infected with parental MCMV at an MOI of 0.05.
24 hours post-transfection or 4 h post-stimulation or infection,
cells were permeabilized with ice-cold methanol for 5 min at 20°C
followed by fixation with 4% PFA in PBS for 20 min at RT. Cells
were washed three times with PBS and then incubated in 10% FCS
and 1% BSA in PBS for 1 h at room temperature. Primary antibodies
diluted in 1% BSA in PBS were added overnight at 4°C, followed by
three PBS washes. Cells were incubated with secondary antibodies
coupled to Alexa488, Alexa594, or Alexa647 and Hoechst (Thermo
Fisher Scientific, #33342) diluted in 1% BSA in PBS for 45 min at
room temperature. Coverslips were mounted on glass microscope
slides with Prolong Gold (Invitrogen). Imaging was performed on a
Nikon ECLIPSE Ti-E-inverted microscope equipped with a spinning
disk device (Perkin Elmer Ultraview), and images were processed
using Volocity software (version 6.2.1, Perkin Elmer).
Immunoblotting
For co-immunoprecipitation (co-IP) experiments in 293T cells,
6 × 105 cells were transiently transfected with 4 lg total DNA
complexed with 15 ll PEI and diluted to 300 ll with OptiMEM.
24 hours post-stimulation, cells were lysed in 1% NP-40 lysis buffer
(50 mM Tris–HCl pH 7.4, 150 mM NaCl, 0.5 mM EDTA, 1%
IGEPAL CA-630 (NP-40 replacement)). Protease and phosphatase
inhibitors were added freshly to all lysis buffers prior to use.
iMEF stably expressing ev or m152-V5 or iMEFgt/gt stably
expressing Cherry-STING and either V5-tagged m152 or the corre-
sponding control cells (2.5 × 105 cells/well, 6-well format) were
stimulated by transfection with 5 or 10 lg/ml ISD complexed with
Lipofectamine and lysed in radioimmunoprecipitation (RIPA)
buffer (20 mM Tris–HCl pH 7.5, 1 mM EDTA, 100 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS). For the
detection of STING dimers, a modified lysis buffer was used
consisting of 25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1% IGELPAL
CA-630, 1% sodium deoxycholate, and 0.1% SDS. When using
Brefeldin A (BFA), an inhibitor for protein transport from the ER
to the Golgi compartment, cells were pretreated with BFA (10 lg/
ml) for 60 min prior to stimulation and during the stimulation.
iMEF WT or iMEFgt/gt (2.5 × 105 cells/well, 6-well format) were
infected with parental MCMV or MCMV m152stop at an MOI of 0.5
and infection was enhanced by centrifugation at 805 × g at 4°C for
30 min. For the analysis of STING signaling kinetics upon MCMV
infection, iMEF WT (2.5 × 105 cells/well, 6-well format) were
infected with parental MCMV or MCMV m152stop at an MOI of 0.1
and the infection was enhanced by centrifugation at 805 × g at 4°C
for 30 min. After centrifugation (defined as time point 0), cells were
incubated at 37°C and 7.5% CO2 for 30 min followed by replace-
ment of virus-containing medium with fresh medium. Cells were
lysed at indicated time points in 1% NP-40 lysis buffer as stated
above.
For co-IPs, one-tenth of the lysate was reserved as input lysate,
and the remainder was pre-cleared with protein A agarose beads
(IPA300, Repligen). Cleared lysates were then incubated with indi-
cated antibodies overnight at 4°C, and protein A agarose beads were
added for 1 h. Beads were washed at least 6 times with 1% NP-40
lysis buffer and bound protein was eluted by heating samples in
SDS sample buffer. Input lysates and IP samples were then analyzed
by immunoblotting.
Cell lysates and samples were separated by SDS–PAGE and trans-
ferred to nitrocellulose or PVDF membrane (both GE Healthcare)
using wet transfer and Towbin blotting buffer (25 mM Tris,
192 mM glycine, 20% (v/v) methanol (pH 8.3)). Membranes were
probed with the indicated primary antibodies and respective
secondary HRP-coupled antibodies diluted in 5% w/v non-fat dry
milk or 5% BSA in TBS-T. Immunoblots were developed with Lumi-
Light (Roche) or SuperSignal West Femto (Thermo Fisher Scientific)
chemiluminescence substrates. Membranes were exposed to films
or imaged with a ChemoStar ECL Imager (INTAS). Images were
prepared using Adobe Photoshop CS5.
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Live cell imaging
Live cell imaging was performed on a Nikon ECLIPSE Ti-E-inverted
microscope equipped with a spinning disk device (Perkin Elmer
Ultraview), and movies were recorded and processed using Volocity
software (Perkin Elmer).
iMEFgt/gt were seeded onto a 8-well chamber slide (Sarstedt #
94.6190.802) for imaging. On the next day, iMEFgt/gt stably express-
ing Cherry-STING and ev were infected with parental MCMV or
MCMV m152stop at an MOI of 0.5 and infection was enhanced by
centrifugation at 805 × g at 4°C for 30 min. For each virus, two wells
were infected. After centrifugation (defined as time point 0), the
chamber slide was placed onto the microscope housed in a humidi-
fied CO2 chamber pre-heated to 37°C. For each experiment, 5 views
were randomly selected per well for imaging. 45 min post-infection,
virus-containing medium was replaced with fresh medium prior to
the commencement of live cell imaging/capture. iMEFgt/gt stably
expressing Cherry-STING and either ev or V5-tagged m152 were stim-
ulated by transfection of 5 lg/ml ISD complexed with Lipofectamine.
For each cell line, two wells were stimulated. Imaging was set up as
described above and initiated after addition of ISD to the cells.
Cells were imaged for up to 4 h and STING translocation was
quantified 120 min and 180 min post-ISD stimulation or infection.
To quantify STING translocation, cells with a distinct STING perinu-
clear localization were counted and expressed as the percentage of
the total number of cells per view. Each data point represents one
live cell imaging movie of a single viewpoint, with a minimum of 75
cells captured per view.
Statistical analysis
Differences between two data sets were evaluated by Student’s t-test
(unpaired, two-tailed), in the case of viral transcript levels after log
transformation of the data sets, using GraphPad Prism version 5.0
(GraphPad Software, San Diego, CA). P-values < 0.05 were consid-
ered statistically significant.
Expanded View for this article is available online.
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